Chi Van Dang

Chi Van Dang is a renowned cancer biologist, hematologist-oncologist, and the Scientific Director of the Ludwig Institute for Cancer Research.1 He is also the Bloomberg Distinguished Professor of Cancer Medicine at Johns Hopkins University.2

Career Highlights

• Appointed Scientific Director of the Ludwig Institute for Cancer Research in July 201713
• Former Director of the Abramson Cancer Center at the University of Pennsylvania (2011-2017)14
• Previously held various positions at Johns Hopkins University, including Vice Dean for Research and Director of the Institute for Cell Engineering2

Research Contributions

Dr. Dang is best known for his groundbreaking research that established the first link between the cancer gene Myc and the aberrant metabolism of cancer cells.1 His work has:

• Explained the "Warburg effect," a hallmark of cancer1
• Contributed to the understanding of how genetic alterations in cancers reprogram fuel utilization by tumors2
• Led to the development of therapies currently in various stages of clinical development1

Education and Achievements

• PhD in Chemistry from Georgetown University1
• MD from Johns Hopkins University1
• Member of the National Academy of Medicine1
• Fellow of the American Academy of Arts and Sciences1
• Chair of the National Cancer Institute's Board of Scientific Advisors1

Current Roles

As Scientific Director of the Ludwig Institute for Cancer Research, Dr. Dang:

• Shapes scientific strategy and oversees operations of its branches in Lausanne, Oxford, Princeton, and San Diego2
• Catalyzes interactions among six Ludwig research centers at major U.S. institutions2
• Continues his cancer biology research, with his laboratory housed at Johns Hopkins University2

Dr. Chi Van Dang's extensive experience in both research and leadership positions has made him a prominent figure in the field of cancer research, driving advancements in understanding cancer metabolism and developing potential new therapies.